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1* The effect of the UPR and NMD mechanisms on the response to
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Genetics, Jerusalem, Israel; 2Max-Planck-Institute for Biochemistry, Proteomics
and Signal Transduction, Martinsried, Germany
Readthrough of nonsense mutations generates full length proteins. Variable response
to readthrough treatment was found to correlate with CFTR transcript levels.
Nonsense Mediated mRNA Decay (NMD) mechanism degrades nonsense carrying
transcripts and affects the readthrough response. The CFTR protein is folded in
the ER. Accumulation of unfolded proteins in the ER activates the Unfolded
Protein Response (UPR), which alters the cellular transcription and translation.
Since inefﬁcient NMD leads to translation of truncated proteins that are not correctly
folded we hypothesize that:
1. Inefﬁcient NMD leads to accumulation of truncated proteins in the ER that
activates the UPR.
2. UPR further inhibits the NMD (which is translational dependent).
Results: Downregulation of the NMD by siRNA directed against hUPF1 induced
the UPR, indicated by increased levels of UPR markers. Importantly, UPR activation
by TM or DTT inhibited the NMD as revealed by increased levels of physiological
NMD substrates. Subsequently, we studied 2 sisters homozygous for the W1282X
mutations of whom one responded to readthrough treatments and had higher CFTR
transcript level. Using SILAC we compared the entire proteome between cells
derived from these sisters. Out of 6000 analyzed proteins, 440 showed a signiﬁcant
different level between the cell lines. At least 44 were ER proteins functioning in
the UPR. Strikingly, a ~2 fold higher level of each of these proteins was found in
the responding sister, indicating a higher UPR activation.
Conclusion: A positive feedback regulation between NMD and UPR pathways
regulates the level of transcripts carrying PTCs and the response to readthrough
treatments.
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In the airways Cl− ions are secreted by the Cystic Fibrosis Transmembrane
conductance Regulator (CFTR) channel that also limits Na+ absorption by partially
repressing the Epithelial Na+ Channel (ENaC). The mechanisms regulating the
transcription of the 3 ENaC genes (SCNN1A, SCNN1B and SCNN1G) are not
fully elucidated and only sporadic experimental evidence exists on their possible
epigenetic regulation.
We studied the expression of the 3 ENaC genes and the DNA methylation levels of
their 5′-ﬂanking regions in H441, MCF10A, 16HBE, CFBE and HACAT in vitro
cell lines, as well as in nasal brushing, granulocytes, lymphocytes and monocytes
of subjects with no Cystic Fibrosis (CF).
We evidenced high expression of all ENaC genes in H441, MCF10A and HA-
CAT cell lines, as well as in nasal brushing. Extremely low, if any, ENaC
expression was found in the 16HBE and CFBE cell lines as well as in granulocytes,
lymphocytes and monocytes. In these expressing and non-expressing experimental
conditions we found an inverse correlation between expression and DNA methyla-
tion of each of the 3 analyzed zones of the 5′-ﬂanking the SCNN1A gene. One of
the 4 analyzed zones of the 5′-ﬂanking region of the SCNN1B gene was constantly
hypomethylated, apart from the gene expression levels; the other 3 zones were
instead always methylated. Studies of the methylation pattern of SCNN1G gene are
still underway.
These studies point to a role of DNA methylation in the transcriptional control of
ENaC genes. They may be of interest for the comprehension of the mechanisms of
CFTR–ENaC interaction and possibly for an optimization of therapeutic strategies
for CF involving ENaC inhibition.
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Disease severity in cystic ﬁbrosis (CF) varies greatly among patients, even when
they carry the same CFTR mutation. This might partially be due to environmental
factors, yet sibling studies strongly indicate that genes other than CFTR modify CF
disease outcome.
Syntaxin 1A (STX1A) has been reported as negative regulator of CFTR and other
ion channels. We hypothesized that STX1A acts as CF modiﬁer by inﬂuencing
the remaining function of mutated CFTR. Applying linear mixed models to data
obtained with the Bernese CF cohort revealed STX1A c.204 T>C to inﬂuence lung
function parameters. Subsequent genotyping of c.204 T>C in the European CF sib
and twin study revealed signiﬁcant differences in allele frequency between mildly
and severely affected sib pairs, thus conﬁrming that the polymorphism modiﬁes CF
pulmonary disease.
Considering that c.204 T>C does not change the amino acid sequence of STX1A,
we investigated its consequences on mRNA level. We show that c.204C reinforces
an aberrant partial inclusion of STX1A intron 3, leading to nonsense mediated
mRNA decay (NMD). Accordingly, c.204 C should be lower expressed, which is
currently investigated by means of allele-speciﬁc quantiﬁcation. Our results further
indicate that STX1A mRNA expression is very low in epithelial tissues. Instead,
we ﬁnd STX1C, a splice-isoform of STX1A, to be up to 100 fold higher expressed
than STX1A, indicating that not STX1A, but rather STX1C is an important player
in CF pathophysiology. This ﬁnding additionally suggests that the exact role of
STX1A in CFTR regulation should possibly be reconsidered.
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Since its introduction, molecular diagnostics of CF in Serbia has been performed
either by direct detection of the most common 7 mutations (F508del, G542X,
G551D, R553X, N1303K, 621+1G>T, 1717−1G>A), use of commercially available
kits, or combination of SSCP/DGGE and sequencing of selected exons of CFTR
gene. In the last three years, in cases where clinical diagnosis of CF was not
conﬁrmed by molecular diagnostics using direct mutation testing, the whole gene
sequencing was standardized and introduced as a routine diagnostic method.
Here we present the results of the whole CFTR gene screening by direct DNA
sequencing in 14 patients with clinical diagnosis of CF.
Mutation was detected on 24 of 28 chromosomes analyzed. High heterogeneity of
detected mutations was observed. Besides F508del, as the most common mutation,
9 other mutations were detected (E585X, 457TAT>G, 1525−1G>A, 4105delA,
G126D, R1185X, 2907delTT, 2723delTT, R1070Q). Their distribution was as
follows: F508del − 45.8%, E585X − 12.5%, 457TAT>G and 1525−1G>A − 8.3%,
each and all others 4.2%, each. With exception of F508del, none of the detected
mutations is a part of a core panel of commercially available kits.
These results give support to our strategy for molecular CF diagnostics in Serbian
patients which combines direct testing for the presence of F508del as the most
frequent mutation in our population, followed by the sequencing of the exons
containing the most frequent mutations in our population (1, 3, 4, 5, 6a, 7, 9,
10, 11, 12, 13, 14a, 15, 17b, 19, 20, 21), and whole gene screening if necessary. To
further improve the diagnostics of CF in our country we plan to introduce analysis
of CFTR gene rearrangements.
